Composition for treating or preventing hyperuricemia
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- MARUHA
- Publication Date
- 2005-08-17
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a composition for treating or preventing hyperuricemia having an effect of lowering serum uric acid level. Background technique
[0002] With the improvement of diet and living standards in recent years, gout has become a serious lifestyle-related disease. It is known that gout is caused by the deposition of excess uric acid produced in the body as calcium urate in the hands, fingers (toes), etc., and severe pain occurs suddenly. The treatment of gout is carried out as follows: ①Use a uric acid synthesis inhibitor to suppress the accumulation of uric acid in the body; and ②Use a uric acid excretion accelerator and a urine alkalizer to rapidly excrete the accumulated uric acid in the body.
[0003] Currently, there is, for example, allopurinol as an easily available uric acid synthesis inhibitor. As uric acid excretion accelerators, probenecid, mesulfazone, and benzbromarone are known. However, allopurinol is known to...